pfizer had offered # 55-a-share to uk rival on basis it was their best offer .
but astrazeneca has turned it down , which could kill the controversial deal .
decision sends its share price down 13 % to # 42 each as markets open .
bosses say deal only offers ` uncertainty and risk ' for its shareholders .
they rejected earlier bid of # 50-a-share because it ` undervalued ' company .